Royal Bank of Canada’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.17M | Buy |
13,275
+7,818
| +143% | +$674K | ﹤0.01% | 3502 |
|
|
2025
Q4 | $429K | Sell |
5,457
-21,425
| -80% | -$1.63M | ﹤0.01% | 4282 |
|
|
2025
Q3 | $1.8M | Sell |
26,882
-10,396
| -28% | -$748K | ﹤0.01% | 3488 |
|
|
2025
Q2 | $3.51M | Buy |
37,278
+6,506
| +21% | +$714K | ﹤0.01% | 2861 |
|
|
2025
Q1 | $3.65M | Buy |
30,772
+353
| +1% | +$48.1K | ﹤0.01% | 2515 |
|
|
2024
Q4 | $4.01M | Sell |
30,419
-580
| -2% | -$71.2K | ﹤0.01% | 2490 |
|
|
2024
Q3 | $4.03M | Sell |
30,999
-2,868
| -8% | -$337K | ﹤0.01% | 2450 |
|
|
2024
Q2 | $2.94M | Sell |
33,867
-521
| -2% | -$54.6K | ﹤0.01% | 2605 |
|
|
2024
Q1 | $3.77M | Buy |
34,388
+2,541
| +8% | +$256K | ﹤0.01% | 2405 |
|
|
2023
Q4 | $3.34M | Sell |
31,847
-987
| -3% | -$96.2K | ﹤0.01% | 2599 |
|
|
2023
Q3 | $3.45M | Buy |
32,834
+803
| +3% | +$103K | ﹤0.01% | 2383 |
|
|
2023
Q2 | $4.12M | Sell |
32,031
-381
| -1% | -$58.1K | ﹤0.01% | 2245 |
|
|
2023
Q1 | $5.66M | Buy |
32,412
+133
| +0.4% | +$23.8K | ﹤0.01% | 1982 |
|
|
2022
Q4 | $5.37M | Buy |
32,279
+5,844
| +22% | +$916K | ﹤0.01% | 2080 |
|
|
2022
Q3 | $3.72M | Sell |
26,435
-194
| -0.7% | -$35.4K | ﹤0.01% | 2312 |
|
|
2022
Q2 | $5.43M | Buy |
26,629
+1,029
| +4% | +$225K | ﹤0.01% | 2041 |
|
|
2022
Q1 | $6.52M | Buy |
25,600
+1,216
| +5% | +$330K | ﹤0.01% | 2035 |
|
|
2021
Q4 | $8M | Buy |
24,384
+902
| +4% | +$283K | ﹤0.01% | 2045 |
|
|
2021
Q3 | $7.1M | Buy |
23,482
+1,423
| +6% | +$404K | ﹤0.01% | 2061 |
|
|
2021
Q2 | $5.98M | Buy |
22,059
+1,695
| +8% | +$430K | ﹤0.01% | 2195 |
|
|
2021
Q1 | $4.96M | Sell |
20,364
-1,431
| -7% | -$394K | ﹤0.01% | 2245 |
|
|
2020
Q4 | $6.25M | Buy |
21,795
+386
| +2% | +$106K | ﹤0.01% | 2038 |
|
|
2020
Q3 | $5.46M | Buy |
21,409
+967
| +5% | +$230K | ﹤0.01% | 1951 |
|
|
2020
Q2 | $4.43M | Buy |
20,442
+1,445
| +8% | +$333K | ﹤0.01% | 2021 |
|
|
2020
Q1 | $4.29M | Buy |
18,997
+3,348
| +21% | +$826K | ﹤0.01% | 1922 |
|
|
2019
Q4 | $3.9M | Buy |
15,649
+1,926
| +14% | +$451K | ﹤0.01% | 2350 |
|
|
2019
Q3 | $3.26M | Buy |
13,723
+1,717
| +14% | +$397K | ﹤0.01% | 2369 |
|
|
2019
Q2 | $2.93M | Buy |
12,006
+1,057
| +10% | +$246K | ﹤0.01% | 2468 |
|
|
2019
Q1 | $2.52M | Buy |
10,949
+838
| +8% | +$189K | ﹤0.01% | 2509 |
|
|
2018
Q4 | $2.11M | Buy |
10,111
+1,228
| +14% | +$239K | ﹤0.01% | 2603 |
|
|
2018
Q3 | $1.65M | Buy |
8,883
+3,318
| +60% | +$668K | ﹤0.01% | 2986 |
|
|
2018
Q2 | $1.17M | Buy |
5,565
+549
| +11% | +$96.1K | ﹤0.01% | 3109 |
|
|
2018
Q1 | $745K | Buy |
5,016
+994
| +25% | +$136K | ﹤0.01% | 3391 |
|
|
2017
Q4 | $499K | Buy |
4,022
+297
| +8% | +$41.5K | ﹤0.01% | 3795 |
|
|
2017
Q3 | $556K | Buy |
3,725
+996
| +36% | +$140K | ﹤0.01% | 3710 |
|
|
2017
Q2 | $391K | Sell |
2,729
-359
| -12% | -$51K | ﹤0.01% | 3859 |
|
|
2017
Q1 | $378K | Buy |
3,088
+583
| +23% | +$71.4K | ﹤0.01% | 3864 |
|
|
2016
Q4 | $307K | Buy |
2,505
+983
| +65% | +$123K | ﹤0.01% | 4186 |
|
|
2016
Q3 | $174K | Buy |
1,522
+389
| +34% | +$44.3K | ﹤0.01% | 4525 |
|
|
2016
Q2 | $139K | Sell |
1,133
-96
| -8% | -$10.3K | ﹤0.01% | 4617 |
|
|
2016
Q1 | $118K | Buy |
1,229
+625
| +103% | +$56.3K | ﹤0.01% | 4680 |
|
|
2015
Q4 | $60K | Buy |
604
+412
| +215% | +$44.1K | ﹤0.01% | 5208 |
|
|
2015
Q3 | $22K | Sell |
192
-115
| -37% | -$12.2K | ﹤0.01% | 5527 |
|
|
2015
Q2 | $27K | Buy |
307
+262
| +582% | +$22.1K | ﹤0.01% | 5545 |
|
|
2015
Q1 | $4K | Buy |
+45
| New | +$3.35K | ﹤0.01% | 5795 |
|
|
2013
Q4 | – | Sell |
-123
| Closed | -$8K | – | 6054 |
|
|
2013
Q3 | $8K | Buy |
+123
| New | +$7.86K | ﹤0.01% | 5490 |
|
Other funds holding MLAB
LPP
VCM
RIM
RA
Royal Bank of Canada's MLAB Position: Q1 2026 in Review
Royal Bank of Canada increased its Mesa Laboratories (MLAB) stake by 143% in Q1 2026, buying an estimated $674K and bringing the position to 13,275 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #3502.
Royal Bank of Canada first reported a position in MLAB in Q3 2013 and has held it in 46 quarters since. The position peaked at $8M in Q4 2021. 161 funds tracked by Wall St. Rank hold MLAB as of Q1 2026.
- Royal Bank of Canada held 13,275 shares of Mesa Laboratories worth $1.17M as of Q1 2026.
- Royal Bank of Canada bought 7,818 Mesa Laboratories shares in Q1 2026, an estimated $674K.
- Mesa Laboratories made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3502 holding.
- Royal Bank of Canada first reported a position in Mesa Laboratories in Q3 2013 and has held it in 46 quarters since.
- Royal Bank of Canada's Mesa Laboratories position peaked at $8M in Q4 2021.
- 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.